Obalon Therapeutics Inc. Common Stock (NASDAQ: OBLN)
Company Name:Obalon Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: OBLN
Class Period Start:10/06/2016
Class Period End (inclusive):05/11/2018
Filing Deadline:04/16/2018
Obalon is purportedly a medical device company that develops and commercializes medical devices to treat obese and overweight people by facilitating weight loss. The Company claims that its initial product offering is the Obalon
balloon system, a U.S. Food and Drug Administration (“FDA”) approved swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients.